Lionco Pharm Grp Co Ltd (603669) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.108x

Based on the latest financial reports, Lionco Pharm Grp Co Ltd (603669) has a cash flow conversion efficiency ratio of -0.108x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-79.09 Million ≈ $-11.57 Million USD) by net assets (CN¥735.30 Million ≈ $107.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Lionco Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Lionco Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603669 liabilities breakdown for a breakdown of total debt and financial obligations.

Lionco Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lionco Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nexity PA:NXI	0.016x
Myoung Shin Industrial Co Ltd KO:009900	0.115x
B+S GROUP SA INH EO-06 F:70B	N/A
Joy Kie Corporation Limited. SHE:300994	0.053x
San Fu Chemical Co Ltd TW:4755	0.044x
Argosy Research TWO:3217	0.110x
Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd. SHE:301040	N/A
Aberdeen Standard Global Infrastructure Income Fund NYSE:ASGI	N/A

Annual Cash Flow Conversion Efficiency for Lionco Pharm Grp Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Lionco Pharm Grp Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Lionco Pharm Grp Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥769.76 Million ≈ $112.64 Million	CN¥-110.89 Million ≈ $-16.23 Million	-0.144x	-254.12%
2023-12-31	CN¥931.04 Million ≈ $136.24 Million	CN¥-37.87 Million ≈ $-5.54 Million	-0.041x	+30.41%
2022-12-31	CN¥1.14 Billion ≈ $166.11 Million	CN¥-66.36 Million ≈ $-9.71 Million	-0.058x	-166.36%
2021-12-31	CN¥1.46 Billion ≈ $213.47 Million	CN¥128.50 Million ≈ $18.80 Million	0.088x	+2.79%
2020-12-31	CN¥1.48 Billion ≈ $216.55 Million	CN¥126.81 Million ≈ $18.56 Million	0.086x	-52.21%
2019-12-31	CN¥1.31 Billion ≈ $192.25 Million	CN¥235.61 Million ≈ $34.48 Million	0.179x	+32.94%
2018-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥185.87 Million ≈ $27.20 Million	0.135x	-7.27%
2017-12-31	CN¥1.30 Billion ≈ $190.12 Million	CN¥189.01 Million ≈ $27.66 Million	0.145x	-6.66%
2016-12-31	CN¥1.17 Billion ≈ $171.13 Million	CN¥182.27 Million ≈ $26.67 Million	0.156x	+76.47%
2015-12-31	CN¥1.12 Billion ≈ $163.82 Million	CN¥98.88 Million ≈ $14.47 Million	0.088x	-81.79%
2014-12-31	CN¥374.13 Million ≈ $54.75 Million	CN¥181.50 Million ≈ $26.56 Million	0.485x	+5.92%
2013-12-31	CN¥351.02 Million ≈ $51.37 Million	CN¥160.77 Million ≈ $23.53 Million	0.458x	-24.13%
2012-12-31	CN¥236.22 Million ≈ $34.57 Million	CN¥142.61 Million ≈ $20.87 Million	0.604x	-20.99%
2011-12-31	CN¥128.55 Million ≈ $18.81 Million	CN¥98.23 Million ≈ $14.37 Million	0.764x	--

About Lionco Pharm Grp Co Ltd

SHG:603669 China Drug Manufacturers - Specialty & Generic

Market Cap

$472.82 Million

CN¥3.23 Billion CNY

Market Cap Rank

#12813 Global

#4009 in China

Share Price

CN¥4.48

Change (1 day)

-1.54%

52-Week Range

CN¥4.05 - CN¥6.97

All Time High

CN¥12.67